John C Stendahl

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Left Ventricular

Hypertrophic Cardiomyopathy

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmad Masri, Steven J Lester, John C Stendahl, Sheila M Hegde, Amy J Sehnert, Ganesh Balaratnam, Ashish Shah, Shawna Fox, Andrew Wang
Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study. Journal of the American Heart Association 13 (8) (2024)
Ahmad Masri, Steven J Lester, John C Stendahl, Sheila M Hegde, Amy J Sehnert, Ganesh Balaratnam, Ashish Shah, Shawna Fox, Andrew Wang
Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study. Journal of the American Heart Association 13 (8) (2024)
Ahmad Masri, Steven J Lester, John C Stendahl, Sheila M Hegde, Amy J Sehnert, Ganesh Balaratnam, Ashish Shah, Shawna Fox, Andrew Wang
Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study. Journal of the American Heart Association (2024)
Ahmad Masri, Steven J Lester, John C Stendahl, Sheila M Hegde, Amy J Sehnert, Ganesh Balaratnam, Ashish Shah, Shawna Fox, Andrew Wang
Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study. Journal of the American Heart Association 13 (8) (2024)
Ahmad Masri, Steven J Lester, John C Stendahl, Sheila M Hegde, Amy J Sehnert, Ganesh Balaratnam, Ashish Shah, Shawna Fox, Andrew Wang
Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study. Journal of the American Heart Association 13 (8) (2024)
Ahmad Masri, Steven J Lester, John C Stendahl, Sheila M Hegde, Amy J Sehnert, Ganesh Balaratnam, Ashish Shah, Shawna Fox, Andrew Wang
Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study. Journal of the American Heart Association 13 (8) (2024)